المؤلفون: Li G; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Liu X; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Gu C; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Ma G; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Li S; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Ma Z; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Xiong Y; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Jiang Y; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Huang Q; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Wu J; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Wu Z; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Liao W; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China., Wu Q; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. wuqijingsmu@126.com., Shi M; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. nfyyshimin@163.com.

المصدر: Journal of translational medicine [J Transl Med] 2024 Aug 03; Vol. 22 (1), pp. 718. Date of Electronic Publication: 2024 Aug 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes*/immunology , Drug Resistance, Neoplasm* , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , NK Cell Lectin-Like Receptor Subfamily C*/metabolism , Stomach Neoplasms*/immunology , Stomach Neoplasms*/genetics , Stomach Neoplasms*/pathology, Humans ; Cell Differentiation ; Gene Expression Regulation, Neoplastic ; Immune Checkpoint Proteins/metabolism ; Immune Checkpoint Proteins/genetics ; Programmed Cell Death 1 Receptor/metabolism

المؤلفون: Yang XL; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China., Zeng Z; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China., Wang C; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China., Wang GY; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China., Zhang FQ; Department of Radiation Oncology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China. zhangfqpumch@163.com.

المصدر: Immunologic research [Immunol Res] 2024 Aug; Vol. 72 (4), pp. 851-863. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 8611087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0755 (Electronic) Linking ISSN: 0257277X NLM ISO Abbreviation: Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma of Lung*/genetics , Adenocarcinoma of Lung*/immunology , Adenocarcinoma of Lung*/mortality , Adenocarcinoma of Lung*/therapy , Adenocarcinoma of Lung*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/immunology , Lung Neoplasms*/therapy , Lung Neoplasms*/mortality , Lung Neoplasms*/drug therapy , Lung Neoplasms*/diagnosis , Machine Learning* , Nomograms* , Immunotherapy*/methods , Immune Checkpoint Inhibitors*/therapeutic use, Humans ; Prognosis ; Biomarkers, Tumor/genetics ; Cohort Studies ; Immune Checkpoint Proteins/genetics ; Immune Checkpoint Proteins/metabolism ; Female ; Algorithms ; Male ; Treatment Outcome ; Middle Aged

المؤلفون: Okita R; Department of Thoracic Surgery, National Hospital Organization Yamaguchi Ube Medical Center, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan. riki0716okita@yahoo.co.jp., Senoo T; Department of Thoracic Surgery, National Hospital Organization Yamaguchi Ube Medical Center, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan., Mimura-Kimura Y; Department of Clinical Research, National Hospital Organization Yamaguchi Ube Medical Center, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan., Mimura Y; Department of Clinical Research, National Hospital Organization Yamaguchi Ube Medical Center, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan., Murakami T; Department of Clinical Research, National Hospital Organization Yamaguchi Ube Medical Center, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan.; Department of Pathology, KYURIN/KYURIN PACELL Corporation, 26-67 Morishita-Cho, Yahatanishi-Ku, Kitakyushu, Fukuoka, 806-0046, Japan., Ikeda E; Department of Clinical Research, National Hospital Organization Yamaguchi Ube Medical Center, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan.; Department of Pathology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan., Okada M; Department of Thoracic Surgery, National Hospital Organization Yamaguchi Ube Medical Center, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan., Inokawa H; Department of Thoracic Surgery, National Hospital Organization Yamaguchi Ube Medical Center, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan., Aoe K; Department of Medical Oncology, National Hospital Organization Yamaguchi Ube Medical Center, Higashikiwa 685, Ube, Yamaguchi, 755-0241, Japan.

المصدر: Scientific reports [Sci Rep] 2024 Jul 10; Vol. 14 (1), pp. 15947. Date of Electronic Publication: 2024 Jul 10.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Mesothelioma, Malignant*/metabolism , Mesothelioma, Malignant*/pathology , Mesothelioma, Malignant*/drug therapy , Pleural Effusion, Malignant*/metabolism , Pleural Effusion, Malignant*/pathology , Pleural Effusion, Malignant*/immunology , Transforming Growth Factor beta1*/metabolism , Transforming Growth Factor beta2*/metabolism , Immune Checkpoint Proteins*/metabolism , Immune Checkpoint Proteins*/genetics, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Transforming Growth Factor beta3/metabolism ; Biomarkers, Tumor/metabolism ; CTLA-4 Antigen/metabolism ; Immune Checkpoint Inhibitors/therapeutic use ; B7-H1 Antigen/metabolism ; Prognosis ; Pleural Neoplasms/metabolism ; Pleural Neoplasms/pathology ; Aged, 80 and over ; Programmed Cell Death 1 Receptor/metabolism ; Adult

المؤلفون: Agostini M; Istituto di Ricerca Pediatrica Città della Speranza, Corso Stati Uniti 4, 35100 Padova, Italy., Traldi P; Istituto di Ricerca Pediatrica Città della Speranza, Corso Stati Uniti 4, 35100 Padova, Italy., Hamdan M; Istituto di Ricerca Pediatrica Città della Speranza, Corso Stati Uniti 4, 35100 Padova, Italy.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 27; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Immune Checkpoint Inhibitors*/therapeutic use , Neoplasms*/drug therapy , Neoplasms*/metabolism , Neoplasms*/immunology , Proteomics*/methods, Humans ; Animals ; Immunotherapy/methods ; Immune Checkpoint Proteins/metabolism

المؤلفون: Righi I; Thoracic Surgery and Lung Transplantation Unit, Department of Cardio- Thoracic - Vascular Disease, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy., Trabattoni D; Department of Biomedical and Clinical Sciences, University of Milan, Via Giovan Battista Grassi 74, 20157 Milan, Italy., Rosso L; Thoracic Surgery and Lung Transplantation Unit, Department of Cardio- Thoracic - Vascular Disease, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan Via Francesco Sforza 12, 20122, Milan, Italy., Vaira V; Department of Pathophysiology and Transplantation, University of Milan Via Francesco Sforza 12, 20122, Milan, Italy; Division of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy., Clerici M; Department of Pathophysiology and Transplantation, University of Milan Via Francesco Sforza 12, 20122, Milan, Italy; IRCCS Fondazione Don Carlo Gnocchi ONLUS, Via Capecelatro 66, 20148 Milan, Italy. Electronic address: mario.clerici@unimi.it.

المصدر: Immunology letters [Immunol Lett] 2024 Jun; Vol. 267, pp. 106860. Date of Electronic Publication: 2024 Apr 25.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7910006 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0542 (Electronic) Linking ISSN: 01652478 NLM ISO Abbreviation: Immunol Lett Subsets: MEDLINE

مواضيع طبية MeSH: Graft Rejection*/immunology , Graft Rejection*/prevention & control , Organ Transplantation*/adverse effects , Immune Checkpoint Proteins*/metabolism , Immune Checkpoint Proteins*/genetics, Humans ; Animals ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology

المؤلفون: Zhang W; Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China., Ou M; Department of Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing Jiangsu, China., Yang P; Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China., Ning M; Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.

المصدر: Clinical and experimental immunology [Clin Exp Immunol] 2024 May 16; Vol. 216 (3), pp. 230-239.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Extracellular Vesicles*/immunology , Neoplasms*/immunology , Neoplasms*/drug therapy , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology, Humans ; Immunomodulation ; Animals ; Immune Checkpoint Proteins/metabolism ; Immune Checkpoint Proteins/genetics ; Immunotherapy/methods ; Tumor Microenvironment/immunology

المؤلفون: Pitts SC; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Schlom J; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. schlomj@mail.nih.gov., Donahue RN; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

المصدر: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 May 31; Vol. 43 (1), pp. 155. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/immunology , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology, Humans ; Prognosis ; Immune Checkpoint Proteins/metabolism ; Biomarkers, Tumor ; Immunotherapy/methods

المؤلفون: Shu X; Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China., Shao Y; Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China., Chen Y; Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China., Zeng C; Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China., Huang X; Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China., Wei R; Department of Ophthalmology, Changzheng Hospital of Naval Medicine University, Shanghai, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 16; Vol. 15, pp. 1392956. Date of Electronic Publication: 2024 May 16 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Graves Ophthalmopathy*/immunology , Graves Ophthalmopathy*/etiology , Graves Ophthalmopathy*/pathology , Immune Checkpoint Inhibitors*/therapeutic use, Humans ; Animals ; Immune Checkpoint Proteins/metabolism ; Immune Checkpoint Proteins/genetics ; Autoantibodies/immunology ; Receptor, IGF Type 1/immunology ; Receptor, IGF Type 1/metabolism ; Receptors, Thyrotropin/immunology ; Receptors, Thyrotropin/metabolism

المؤلفون: Xu P; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Gao Y; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Jiang S; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Cui Y; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Xie Y; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Kang Z; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Chen YX; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Sun D; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: danfolsdf@126.com., Fang JY; Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: jingyuanfang@sjtu.edu.cn.

المصدر: Cancer letters [Cancer Lett] 2024 Apr 28; Vol. 588, pp. 216595. Date of Electronic Publication: 2023 Dec 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

مواضيع طبية MeSH: Immune Checkpoint Inhibitors*/pharmacology , Immune Checkpoint Inhibitors*/therapeutic use , Neoplasms*/drug therapy , Neoplasms*/genetics , Neoplasms*/pathology, Mice ; Animals ; CD8-Positive T-Lymphocytes ; Checkpoint Kinase 2/genetics ; Mutation ; Immunotherapy/methods ; Tumor Microenvironment

المؤلفون: Chen L; Department of Oncology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China., Zhao X; Department of Oncology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China., Liu X; Institute for Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China., Ouyang Y; Acupuncture and Massage College, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China., Xu C; Department of Oncology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China., Shi Y; Department of Oncology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China.

المصدر: Cancer biology & medicine [Cancer Biol Med] 2024 May 09; Vol. 21 (5).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Chinese Anti-Cancer Association Country of Publication: China NLM ID: 101588850 Publication Model: Print Cited Medium: Internet ISSN: 2095-3941 (Print) Linking ISSN: 20953941 NLM ISO Abbreviation: Cancer Biol Med Subsets: MEDLINE

مواضيع طبية MeSH: Immune Checkpoint Inhibitors*/therapeutic use , Neoplasms*/drug therapy , Neoplasms*/immunology, Humans ; Drug Development ; Immune Checkpoint Proteins/metabolism ; Small Molecule Libraries/pharmacology ; Animals ; Immunotherapy/methods